Source:http://linkedlifedata.com/resource/pubmed/id/11049880
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2000-11-15
|
pubmed:abstractText |
Glycyl-glutamine (Gly-Gln; beta-endorphin(30-31)) is an endogenous dipeptide that is synthesized through the posttranslational processing of beta-endorphin in brain stem regions that control respiration and autonomic function. This study tested the hypothesis that Gly-Gln administration to conscious rats will prevent the respiratory depression caused by morphine without affecting morphine antinociception. Rats were administered Gly-Gln (1-100 nmol) or saline (10 microl) intracerebroventricularly followed, 5 min later, by morphine (40 nmol icv). Arterial blood gases and pH were measured immediately before Gly-Gln and 30 min after morphine injection. Gly-Gln pretreatment inhibited morphine-induced hypercapnia, hypoxia, and acidosis significantly. The response was dose dependent and significant at Gly-Gln doses as low as 1 nmol. In contrast, Gly-Gln (1-300 nmol) had no effect on morphine-evoked antinociception in the paw withdrawal test. When given alone to otherwise untreated animals, Gly-Gln did not affect nociceptive latencies or blood gas values. These data indicate that Gly-Gln inhibits morphine-induced respiratory depression without compromising morphine antinociception.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Carbon Dioxide,
http://linkedlifedata.com/resource/pubmed/chemical/Dipeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Morphine,
http://linkedlifedata.com/resource/pubmed/chemical/Oxygen,
http://linkedlifedata.com/resource/pubmed/chemical/glycylglutamine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0363-6119
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
279
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
R1944-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11049880-Acidosis,
pubmed-meshheading:11049880-Analgesia,
pubmed-meshheading:11049880-Animals,
pubmed-meshheading:11049880-Anoxia,
pubmed-meshheading:11049880-Carbon Dioxide,
pubmed-meshheading:11049880-Dipeptides,
pubmed-meshheading:11049880-Hydrogen-Ion Concentration,
pubmed-meshheading:11049880-Hypercapnia,
pubmed-meshheading:11049880-Injections, Intraventricular,
pubmed-meshheading:11049880-Male,
pubmed-meshheading:11049880-Morphine,
pubmed-meshheading:11049880-Oxygen,
pubmed-meshheading:11049880-Pain Measurement,
pubmed-meshheading:11049880-Rats,
pubmed-meshheading:11049880-Rats, Sprague-Dawley,
pubmed-meshheading:11049880-Respiration
|
pubmed:year |
2000
|
pubmed:articleTitle |
Glycyl-glutamine inhibits the respiratory depression, but not the antinociception, produced by morphine.
|
pubmed:affiliation |
Department of Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|